1. JS1.2 Increased frequency of paraneoplastic encephalitis with anti-Ma2 antibodies in the cancer immunotherapy era. (6th September 2019) Authors: Vogrig, A; Fouret, M; Joubert, B; Picard, G; Rogemond, V; Pinto, A; Muñiz Castrillo, S; Roger, M; Raimbourg, J; Dayen, C; Grignou, L; Pallix-Guyot, M; Lannoy, J; Ducray, F; Desestret, V; Psimaras, D; Honnorat, J Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OS3.3 Radiological characteristics and natural history of adult IDH wild type astrocytomas with TERT promoter mutations. (19th September 2018) Authors: Izquierdo, C; Barritault, M; Poncet, D; Cartalat, S; Joubert, B; Bruna, J; Jouanneau, E; Guyotat, J; Vasiljevic, A; Fenouil, T; Berthezène, Y; Honnorat, J; Meyronet, D; Ducray, F Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P01.120 Importance of systematic TERT promoter and IDH mutations screening in non-diagnostic biopsies from patients with a suspected glioma. (19th September 2018) Authors: Barritault, M; Picart, T; Poncet, D; Fenouil, T; Guyotat, J; Jouanneau, E; Joubert, B; Vasiljevic, A; Honnorat, J; Meyronet, D; Ducray, F Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P01.120 Importance of systematic TERT promoter and IDH mutations screening in non-diagnostic biopsies from patients with a suspected glioma. (19th September 2018) Authors: Barritault, M; Picart, T; Poncet, D; Fenouil, T; Guyotat, J; Jouanneau, E; Joubert, B; Vasiljevic, A; Honnorat, J; Meyronet, D; Ducray, F Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P11.66.A Immune checkpoint inhibitors related peripheral nerve disorders: clinical and electrophysiological particularities. (5th September 2022) Authors: Birzu, C; Farina, A; Pegat, A; Devic, P; Lenglet, T; Viala, K; Debs, R; Fargeot, G; Picca, A; Le Guennec, L; Mongin, M; Villette, B; Joubert, B; Maisonobe, T; Psimaras, D Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P14.88 Comparison of SNaPshot PCR and digital droplet PCR for the identification of TERT promoter in non-diagnostic biopsies from glioma patients. (6th September 2019) Authors: Poncet, D; Picart, T; Guyotat, J; Jouanneau, E; Joubert, B; Vasiljevic, A; Honnorat, J; Meyronet, D; Ducray, F; Barritault, M Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗